What is the recommended tapering schedule for discontinuing sertraline (Zoloft) 25mg? | Rounds What is the recommended tapering schedule for discontinuing sertraline (Zoloft) 25mg? | Rounds
Loading...

What is the recommended tapering schedule for discontinuing sertraline (Zoloft) 25mg?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2026 · View editorial policy

Sertraline Discontinuation Tapering Schedule (25 mg)

Sertraline should be discontinued using a slow, stepwise, proportionate dose-reduction schedule rather than abrupt cessation. [1] For antidepressant withdrawal management, dose reductions should be smaller as the dose becomes lower, with dose reductions held for 2 to 4 weeks to assess tolerability. [2]

Core Tapering Principles

Abrupt discontinuation (complete cessation with immediate effect) should be avoided unless exceptional medical circumstances exist. [1] Dose reduction should be planned as a slow, stepwise schedule that becomes smaller as the dose is lowered. [1] If withdrawal symptoms occur, the next dose reduction should be delayed or the prior dose should be resumed before attempting smaller reductions again. [1][2]

Medication Selection Algorithm

A dose-reduction schedule should be implemented using available dose strengths or a formulation that permits proportionate decrements. [2] If smaller decrements are needed below what tablet strengths allow, a liquid formulation or other equivalent dosing option should be used rather than self-splitting tablets or making homemade preparations. [2]

Proposed Example Taper From 25 mg Daily

The schedule below applies the Royal College of Psychiatrists proportionate taper approach using 2 to 4 week adjustment intervals. [2]

  • Reduce sertraline by 50% (from 25 mg to 12.5 mg daily) for 2 to 4 weeks, then assess for withdrawal symptoms. [2]
  • If tolerated, reduce by a further 50% (from 12.5 mg to 6.25 mg daily) for 2 to 4 weeks, then discontinue. [2]

If distressing symptoms occur during any reduction, the next reduction should be held until symptoms improve and future reductions should use smaller decrements (for example, 5% to 10% of the original dose) with doctor follow-up. [2]

Initiation Thresholds and Modification Triggers

A slower taper should be used when antidepressants have been taken for many months or years. [2] A slower taper should be used when distressing withdrawal symptoms developed with a prior attempt to reduce or stop. [2] Regular intervals for review and adjustment of the reduction schedule should be used during withdrawal. [1]

Common Pitfalls to Avoid

Missing doses on some days should be avoided because fluctuating drug levels can increase withdrawal likelihood. [2] Stopping abruptly should be avoided because withdrawal risk increases with rapid dose reduction. [1][2]

Targets or Goals of Therapy

The target during tapering is minimization of withdrawal symptoms while completing discontinuation using a proportionate, stepwise dose-reduction plan. [1][2] The plan should be adjusted based on tolerability at the agreed review intervals. [1]

Management of Withdrawal Symptoms During Taper

If withdrawal symptoms occur after a dose reduction, the schedule should be modified before the next reduction. [1] Withdrawal symptoms should prompt delay of the next reduction or reversion to the last well-tolerated dose. [1][2]

Source References

[1] NICE NG215, “Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults,” recommendation on not stopping abruptly and using a slow, stepwise, proportionate reduction. [1] [2] Royal College of Psychiatrists patient information resource “Stopping antidepressants,” guidance on taper speed, proportionate reductions (25% or 50%), 2 to 4 week adjustment periods, and smaller 5% to 10% reductions for intolerable symptoms. [2]

Related Questions